Predictive oncology stock.

7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.ETFs positionnés sur Predictive Oncology Inc. Nom, Poids, Encours, Varia. 1 janv. Note Invest. VANGUARD TOTAL STOCK MARKET ...

Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35... Predictive Oncology has a market capitalisation of US$21m and burnt through US$13m last year, which is 64% of the company's market value. Given how large that cash burn is, relative to the market ...

Fiscal Q3 2023 ended 9/30/23. Reported on 11/14/23. Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information …

Nov 7, 2023 · Press Releases. Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update. Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital. Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. ... Predictive Oncology Inc. (POAI) Upgraded to Buy: What Does It Mean for the Stock?With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.On April 21, 2023, Predictive Oncology Inc (POAI) experienced a 15.81% drop in share prices, trading at $0.23. This declinePREDICTIVE ONCOLOGY INC. 1,738,357 Shares . Common Stock . This prospectus relates to the offer and resale of up to 1,738,357 shares of our common stock, par value $0.01 per share, by the selling stockholders as listed in the selling stockholders table on page 13 (the “Selling Stockholders”).

Predictive Oncology, Pittsburgh, Pennsylvania. 294 likes. Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery & enabling the de

The estimated Net Worth of Robert L Myers is at least $351 ezer dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $23,211 and over the last 6 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.

Predictive Oncology Pharmaceutical Manufacturing Pittsburgh, PA 1,638 followers Predictive Oncology (NASDAQ:POAI) offers a suite of solutions for oncology drug development from discovery to trials.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...The estimated Net Worth of J Melville Engle is at least $987 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $984,422 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.When is Predictive Oncology's earnings date? Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 19th, 2024 based off last year's report dates. Learn more on POAI's earnings history.Find the latest Predictive Oncology Inc (POAI) discussion and analysis from iHub's community of investors.The latest price target for Predictive Oncology ( NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise ...Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.Predictive Oncology Inc (POAI) stock is trading at $3.14 as of 10:12 AM on Tuesday, May 30, a rise of $0.11, or 3.63% from the previous closing price of $3.03. The stock has traded between $3.07 and $3.37 so far today. Volume today is light. So far 46,967 shares have traded compared to average volume of 244,460 shares. Click Here to get the ...Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock.The average Predictive Oncology stock forecast 2023 represents a 0.36% increase from the last price of $3.08999991416931. For Predictive Oncology stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Predictive Oncology stock forecast of $3.76, a high forecast of $5.03, and a low …For Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.Predictive Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. POAI updated stock price target summary.

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre ...

Predictive Oncology Inc. EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused ...EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused …5. VanEck Biotech ETF. Total assets: $517 million. Expense ratio: 0.35%. Dividend yield: 0.35%. The VanEck Biotech ETF ( BBH 0.9%) tries to own the most liquid biotech companies based on market ...Aug 10, 2023 · Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ... View Predictive Oncology Inc POAI investment & stock information. Get the latest Predictive Oncology Inc POAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find real-time POAI - Predictive Oncology Inc stock quotes, company profile, news and forecasts from CNN Business.

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.

Nov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...

Jun 13, 2023 · Predictive Oncology (POAI) Predictive Oncology (NASDAQ: POAI) is the first of the best tech-based penny stocks to consider. Cancer research has come a long way and yet it still has so far to go ... Mar 22, 2023 · Effective March 16, 2023, Predictive Oncology and Cancer Research Horizons, the world’s largest private funder of cancer research, have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL platform that pairs artificial intelligence (AI) with the world’s largest biobank of tumor samples; Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued. Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Aug 11, 2022 · An increase of cash and equivalents from $25 million on March 31, 2022, to $28 million at quarter end, which represents a positive change of 12%. Q2 2022 financial results. Predictive Oncology’s ... View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …The NFL’s preseason’s about to start, and that means regular season games will be kicking off before we know it. And since we all love to predict the future way before it really makes sense to do so, it feels like a great time to take stock...Aug 10, 2023 · Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ... The NFL’s preseason’s about to start, and that means regular season games will be kicking off before we know it. And since we all love to predict the future way before it really makes sense to do so, it feels like a great time to take stock...Instagram:https://instagram. crc californiacarlyle captrustamzn future stock pricejm smuckers stock Predictive Oncology Inc. EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence and ... dominos ceresautomated investing software Predictive Oncology up 13% premarket on coronavirus mention. SA NewsMon, Mar. 02, 2020. Get the latest news and real-time alerts from Predictive Oncology Inc. (POAI) stock at Seeking Alpha.The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology. is oscar good insurance Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and ...